CIM
Contravisory Investment Management’s Eli Lilly LLY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.49M | Buy |
3,200
+162
| +5% | +$126K | 0.49% | 40 |
|
|
2025
Q1 | $2.51M | Buy |
3,038
+2,423
| +394% | +$2M | 0.53% | 40 |
|
|
2024
Q4 | $475K | Sell |
615
-39
| -6% | -$30.1K | 0.1% | 147 |
|
|
2024
Q3 | $579K | Buy |
654
+34
| +5% | +$30.1K | 0.12% | 112 |
|
|
2024
Q2 | $561K | Sell |
620
-24
| -4% | -$21.7K | 0.12% | 106 |
|
|
2024
Q1 | $501K | Buy |
+644
| New | +$501K | 0.11% | 125 |
|
|
2023
Q2 | – | Sell |
-23,642
| Closed | -$8.12M | – | 343 |
|
|
2023
Q1 | $8.12M | Sell |
23,642
-399
| -2% | -$137K | 2.29% | 8 |
|
|
2022
Q4 | $8.8M | Buy |
24,041
+1,245
| +5% | +$455K | 2.44% | 6 |
|
|
2022
Q3 | $7.37M | Buy |
22,796
+67
| +0.3% | +$21.7K | 2.46% | 4 |
|
|
2022
Q2 | $7.37M | Sell |
22,729
-217
| -0.9% | -$70.4K | 2.39% | 6 |
|
|
2022
Q1 | $6.57M | Buy |
+22,946
| New | +$6.57M | 1.86% | 19 |
|
|
2019
Q3 | – | Sell |
-548
| Closed | -$61K | – | 294 |
|
|
2019
Q2 | $61K | Buy |
+548
| New | +$61K | 0.02% | 215 |
|
|
2016
Q2 | – | Sell |
-25
| Closed | -$2K | – | 222 |
|
|
2016
Q1 | $2K | Hold |
25
| – | – | ﹤0.01% | 164 |
|
|
2015
Q4 | $2K | Buy |
+25
| New | +$2K | ﹤0.01% | 171 |
|
|
2015
Q2 | – | Sell |
-400
| Closed | -$29K | – | 184 |
|
|
2015
Q1 | $29K | Buy |
400
+200
| +100% | +$14.5K | 0.01% | 96 |
|
|
2014
Q4 | $14K | Buy |
+200
| New | +$14K | ﹤0.01% | 111 |
|